The role of CD8+ T cells during allograft rejection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0100-879X2002001100001 http://repositorio.unifesp.br/handle/11600/1544 |
Resumo: | Organ transplantation can be considered as replacement therapy for patients with end-stage organ failure. The percent of one-year allograft survival has increased due, among other factors, to a better understanding of the rejection process and new immunosuppressive drugs. Immunosuppressive therapy used in transplantation prevents activation and proliferation of alloreactive T lymphocytes, although not fully preventing chronic rejection. Recognition by recipient T cells of alloantigens expressed by donor tissues initiates immune destruction of allogeneic transplants. However, there is controversy concerning the relative contribution of CD4+ and CD8+ T cells to allograft rejection. Some animal models indicate that there is an absolute requirement for CD4+ T cells in allogeneic rejection, whereas in others CD4-depleted mice reject certain types of allografts. Moreover, there is evidence that CD8+ T cells are more resistant to immunotherapy and tolerance induction protocols. An intense focal infiltration of mainly CD8+CTLA4+ T lymphocytes during kidney rejection has been described in patients. This suggests that CD8+ T cells could escape from immunosuppression and participate in the rejection process. Our group is primarily interested in the immune mechanisms involved in allograft rejection. Thus, we believe that a better understanding of the role of CD8+ T cells in allograft rejection could indicate new targets for immunotherapy in transplantation. Therefore, the objective of the present review was to focus on the role of the CD8+ T cell population in the rejection of allogeneic tissue. |
id |
UFSP_30095f514300c86b605b2917bc927163 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/1544 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
The role of CD8+ T cells during allograft rejectionTransplantationRejectionT cellsCytokinesChemokinesOrgan transplantation can be considered as replacement therapy for patients with end-stage organ failure. The percent of one-year allograft survival has increased due, among other factors, to a better understanding of the rejection process and new immunosuppressive drugs. Immunosuppressive therapy used in transplantation prevents activation and proliferation of alloreactive T lymphocytes, although not fully preventing chronic rejection. Recognition by recipient T cells of alloantigens expressed by donor tissues initiates immune destruction of allogeneic transplants. However, there is controversy concerning the relative contribution of CD4+ and CD8+ T cells to allograft rejection. Some animal models indicate that there is an absolute requirement for CD4+ T cells in allogeneic rejection, whereas in others CD4-depleted mice reject certain types of allografts. Moreover, there is evidence that CD8+ T cells are more resistant to immunotherapy and tolerance induction protocols. An intense focal infiltration of mainly CD8+CTLA4+ T lymphocytes during kidney rejection has been described in patients. This suggests that CD8+ T cells could escape from immunosuppression and participate in the rejection process. Our group is primarily interested in the immune mechanisms involved in allograft rejection. Thus, we believe that a better understanding of the role of CD8+ T cells in allograft rejection could indicate new targets for immunotherapy in transplantation. Therefore, the objective of the present review was to focus on the role of the CD8+ T cell population in the rejection of allogeneic tissue.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Disciplina de NefrologiaUNIFESP, EPM, Disciplina de NefrologiaSciELOAssociação Brasileira de Divulgação CientíficaUniversidade Federal de São Paulo (UNIFESP)Bueno, Valquiria [UNIFESP]Pestana, Jose Osmar Medina [UNIFESP]2015-06-14T13:29:49Z2015-06-14T13:29:49Z2002-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1247-1258application/pdfhttp://dx.doi.org/10.1590/S0100-879X2002001100001Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 11, p. 1247-1258, 2002.10.1590/S0100-879X2002001100001S0100-879X2002001100001.pdf0100-879XS0100-879X2002001100001http://repositorio.unifesp.br/handle/11600/1544WOS:000179717100001engBrazilian Journal of Medical and Biological Researchinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T22:57:41Zoai:repositorio.unifesp.br/:11600/1544Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T22:57:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
The role of CD8+ T cells during allograft rejection |
title |
The role of CD8+ T cells during allograft rejection |
spellingShingle |
The role of CD8+ T cells during allograft rejection Bueno, Valquiria [UNIFESP] Transplantation Rejection T cells Cytokines Chemokines |
title_short |
The role of CD8+ T cells during allograft rejection |
title_full |
The role of CD8+ T cells during allograft rejection |
title_fullStr |
The role of CD8+ T cells during allograft rejection |
title_full_unstemmed |
The role of CD8+ T cells during allograft rejection |
title_sort |
The role of CD8+ T cells during allograft rejection |
author |
Bueno, Valquiria [UNIFESP] |
author_facet |
Bueno, Valquiria [UNIFESP] Pestana, Jose Osmar Medina [UNIFESP] |
author_role |
author |
author2 |
Pestana, Jose Osmar Medina [UNIFESP] |
author2_role |
author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Bueno, Valquiria [UNIFESP] Pestana, Jose Osmar Medina [UNIFESP] |
dc.subject.por.fl_str_mv |
Transplantation Rejection T cells Cytokines Chemokines |
topic |
Transplantation Rejection T cells Cytokines Chemokines |
description |
Organ transplantation can be considered as replacement therapy for patients with end-stage organ failure. The percent of one-year allograft survival has increased due, among other factors, to a better understanding of the rejection process and new immunosuppressive drugs. Immunosuppressive therapy used in transplantation prevents activation and proliferation of alloreactive T lymphocytes, although not fully preventing chronic rejection. Recognition by recipient T cells of alloantigens expressed by donor tissues initiates immune destruction of allogeneic transplants. However, there is controversy concerning the relative contribution of CD4+ and CD8+ T cells to allograft rejection. Some animal models indicate that there is an absolute requirement for CD4+ T cells in allogeneic rejection, whereas in others CD4-depleted mice reject certain types of allografts. Moreover, there is evidence that CD8+ T cells are more resistant to immunotherapy and tolerance induction protocols. An intense focal infiltration of mainly CD8+CTLA4+ T lymphocytes during kidney rejection has been described in patients. This suggests that CD8+ T cells could escape from immunosuppression and participate in the rejection process. Our group is primarily interested in the immune mechanisms involved in allograft rejection. Thus, we believe that a better understanding of the role of CD8+ T cells in allograft rejection could indicate new targets for immunotherapy in transplantation. Therefore, the objective of the present review was to focus on the role of the CD8+ T cell population in the rejection of allogeneic tissue. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-11-01 2015-06-14T13:29:49Z 2015-06-14T13:29:49Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0100-879X2002001100001 Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 11, p. 1247-1258, 2002. 10.1590/S0100-879X2002001100001 S0100-879X2002001100001.pdf 0100-879X S0100-879X2002001100001 http://repositorio.unifesp.br/handle/11600/1544 WOS:000179717100001 |
url |
http://dx.doi.org/10.1590/S0100-879X2002001100001 http://repositorio.unifesp.br/handle/11600/1544 |
identifier_str_mv |
Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 11, p. 1247-1258, 2002. 10.1590/S0100-879X2002001100001 S0100-879X2002001100001.pdf 0100-879X S0100-879X2002001100001 WOS:000179717100001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1247-1258 application/pdf |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268450625814528 |